Deciphering the domain specificity of C. difficile toxin neutralizing antibodies-Reference-Cited by-同舟云学术

Deciphering the domain specificity of C. difficile toxin neutralizing antibodies

Published:2019-06 Issue:29 Volume:37 Page:3892-3901
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Cole Leah E.,Li Lu,Jetley Utsav,Zhang Jinrong,Pacheco Kristl,Ma Fuqin,Zhang Jianxin,Mundle Sophia,Yan Yanhua,Barone Lucianna,Rogers Christopher,Beltraminelli Nicola,Quemeneur Laurence,Kleanthous Harry,Anderson Stephen F.,Anosova Natalie G.

Funder

Sanofi Pasteur

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. Clostridium difficile infection;Leffler;N Engl J Med,2015

2. Clostridium difficile toxins A and B: Insights into pathogenic properties and extraintestinal effects;Di Bella;Toxins (Basel),2016

3. Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells;Qa’Dan;Cell Microbiol,2002

4. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine;Savidge;Gastroenterology,2003

5. Glucosylation of Rho GTPases by Clostridium Difficile toxin a triggers apoptosis in intestinal epithelial cells;Gerhard;J Med Microbiol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation;Gut Microbes;2024-04-09

2. Multimodal vaccination targeting the receptor binding domains of Clostridioides difficile toxins A and B with an attenuated Salmonella Typhimurium vector (YS1646) protects mice from lethal challenge;Microbiology Spectrum;2024-02-06

3. Clostridioides difficile: Current overview and future perspectives;Immunotherapeutics;2022

4. Receptor binding mechanisms of Clostridioides difficile toxin B and implications for therapeutics development;The FEBS Journal;2021-12-13

5. Harnessing an Integrative In Silico Approach to Engage Highly Immunogenic Peptides in an Antigen Design Against Epsilon Toxin (ETX) of Clostridium perfringens;International Journal of Peptide Research and Therapeutics;2020-11-27